Amgen sued

The Thousand Oaks biotech giant is being accused by the state of New York and 14 other states (CA included) of offering kickbacks to medical providers in order to increase sales of the company's anemia medicine, Aranesp (Amgen's third-biggest drug in 2008). Also sued were two units of AmerisourceBergen. The New York Attorney General's Office was the lead agency. From the Business Journal:

The lawsuit accuses the companies of encouraging medical providers to bill third party payers such as Medicaid for amounts of Aranesp that essentially were provided at no cost. The free product consisted of overfill amounts in the vials of Aranesp they received, the suit contends.

Amgen says the allegations are without merit. Aranesp has been losing sales since 2006 when high doses of the drug were linked to increased rates of heart attack and death in kidney patients.


More by Mark Lacter:
American-US Air settlement with DOJ includes small tweak at LAX
Socal housing market going nowhere fast
Amazon keeps pushing for faster L.A. delivery
Another rugged quarter for Tribune Co. papers
How does Stanford compete with the big boys?
Those awful infographics that promise to explain and only distort
Best to low-ball today's employment report
Further fallout from airport shootings
Crazy opening for Twitter*
Should Twitter be valued at $18 billion?
Recent stories:
Letter from Down Under: Welcome to the Homogenocene
One last Florida photo
Signs of Saturday: No refund
'I Am Woman,' hear them roar
Bobcat crossing
Previous story: *Stocks get whacked

Next story: News Corp. & NBCU?

New at LA Observed
On the Media Page
Go to Media

On the Politics Page
Go to Politics
Arts and culture

Sign up for daily email from LA Observed

Enter your email address:

Delivered by FeedBurner


Advertisement
Mark Lacter
Mark Lacter created the LA Biz Observed blog in 2006. He posted until the day before his death on Nov. 13, 2013.
 
Mark Lacter, business writer and editor was 59
The multi-talented Mark Lacter
LA Observed on Twitter and Facebook